Novel Therapeutic Targets

Autoimmunity results from a break in self-tolerance involving humoral and/or cell-mediated immune mechanisms. One pathological consequence of a failure in central and/or peripheral tolerance is the generation of autoantibodies and subsequent formation of complement-fixing immune complexes that contribute to tissue damage. Prevailing pharmacological strategies for treating autoimmune diseases involve the use of broad-acting immunosuppressants that with long term use have associated toxicities. 

  • Drug Delivery Systems
  • Membrane Proteins/Antagonists & Inhibitors
  • Tumor Necrosis Factor-alpha/Metabolism

Related Conference of Novel Therapeutic Targets

November 21-22, 2019

World Conference on Vaccine and Immunology

MENA Plaza Hotel Albarsha | Dubai, UAE
November 21-22, 2019

14th International Conference on Allergy and Clinical Immunology

Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
December 02-03, 2019

10th International Conference on Immunology & Immunogenetics

Park Inn by Radisson Hotel & Conference Centre London
June 23-24, 2020

34th World Congress on Vaccines and Immunization

Osaka, Japan
September 14-15, 2020

35th World Congress on Immunology

Tokyo, Japan
Oct 12-13, 2020

International Conference on Vaccine and Vaccine Research

Manila, Philippines
October 14-15, 2020

13th International Conference on Allergy & Immunology

Zurich, Switzerland
October 19-20, 2020

lifestylemanagment-cs-2020

Amsterdam, Netherlands

International Conference on Immunology & Immunotherapies

November 18-19, 2020 | Bangkok, Thailand
November 25-26, 2020

International Conference On European Immunology

London, UK

Novel Therapeutic Targets Conference Speakers

Recommended Sessions

Related Journals

Are you interested in